{"news_desk": "Business", "print_page": "1", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By STEPHANIE CLIFFORD and MATTHEW GOLDSTEIN", "person": [{"rank": 1, "role": "reported", "firstname": "Stephanie", "organization": "", "lastname": "CLIFFORD"}, {"rank": 2, "role": "reported", "firstname": "Matthew", "organization": "", "lastname": "GOLDSTEIN"}]}, "abstract": "Federal authorities' indictment of Turing Pharmaceuticals chief executive Martin Shkreli on securities fraud charges portrays his small-time fraud in hiding losses in his hedge funds; contend his Ponzi-like scheme involved looting his former company Retrophin to pay back upset investors.", "type_of_material": "News", "word_count": "1390", "lead_paragraph": "The latest uproar around Martin Shkreli has nothing to do with drug prices, but allegations of fraud at a small hedge fund.", "pub_date": "2015-12-18T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Shkreli Indictment Portrays Small-Time Fraud ", "print_headline": "Shkreli Indictment Portrays Small-Time Fraud "}, "snippet": "The latest uproar around Martin Shkreli has nothing to do with drug prices, but allegations of fraud at a small hedge fund.", "multimedia": [{"height": 126, "url": "images/2015/12/18/business/18INDICT1/18INDICT1-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/12/18/business/18INDICT1/18INDICT1-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 527, "url": "images/2015/12/18/business/18INDICT1/18INDICT1-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "527", "xlarge": "images/2015/12/18/business/18INDICT1/18INDICT1-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/12/18/business/18INDICT1/18INDICT1-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/12/18/business/18INDICT1/18INDICT1-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/12/18/business/dealbook/shkreli-indictment-portrays-small-time-fraud.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Shkreli, Martin (1983- )", "name": "persons"}, {"rank": "2", "is_major": "Y", "value": "Hedge Funds", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "4", "is_major": "Y", "value": "Retrophin Inc", "name": "organizations"}, {"rank": "5", "is_major": "Y", "value": "Turing Pharmaceuticals AG", "name": "organizations"}, {"rank": "6", "is_major": "Y", "value": "Securities and Commodities Violations", "name": "subject"}, {"rank": "7", "is_major": "Y", "value": "MSMB Capital Management LLC", "name": "organizations"}, {"rank": "8", "is_major": "N", "value": "Ponzi and Pyramid Schemes", "name": "subject"}], "blog": [], "_id": "5673622538f0d85bed90f47b", "source": "The New York Times"}